[Urgent] Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

KALV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.50%

Insider Buying (Last 12 Months): $5,806,280.30

Insider Selling (Last 12 Months): $2,762,606.86

KalVista Pharmaceuticals Insider Trading History Chart

KalVista Pharmaceuticals Share Price & Price History

^$11.25

▼ -0.38 (-3.27%)

As of 11/5/2024 01:00 AM ET

Days: 30 | 90 | 365

NASDAQ traded stock with a BIG short position.

From Huge Alerts | Ad

Small cap NASDAQ firm is an innovative leader in non-opioid pain therapeutics. The company’s offerings could significantly aid in stopping the opioid crisis and create maximum shareholder growth!

See how this NASDAQ Bio-tech is offering viable solutions

KalVista Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/9/2024	Benjamin L Palleiko	CEO	Sell	7,352	$12.19	$89,620.88	250,800
8/23/2024	Paul K Audhya	Insider	Sell	2,135	$12.40	$26,474.00	83,745
8/19/2024	Benjamin L Palleiko	CEO	Sell	14,215	$12.01	$170,722.15	242,527
8/19/2024	Christopher Yea	Insider	Sell	7,102	$12.01	$85,295.02	84,467
6/7/2024	Benjamin L Palleiko	CEO	Sell	7,465	$11.53	$86,071.45	224,547
5/20/2024	Benjamin L Palleiko	CEO	Sell	21,959	$11.76	$258,237.84	216,387
5/20/2024	Edward P. Feener	Insider	Sell	8,088	$11.76	$95,114.88	72,858
2/20/2024	Benjamin L Palleiko	CFO	Sell	22,802	$14.11	$321,736.22	187,315
2/20/2024	Edward P. Feener	Insider	Sell	28,288	$14.07	$398,012.16	62,157
2/20/2024	Thomas Andrew Crockett	CEO	Sell	24,888	$14.11	$351,169.68	211,203
2/8/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	29,747	$14.70	$437,280.90	4,824,731
2/6/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	4,474	$14.74	$65,946.76	4,743,157
1/29/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	80,600	$14.22	$1,146,132.00	4,650,584
1/26/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	4,174	$12.98	$54,178.52	4,569,984
1/24/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	20,686	$12.44	$257,333.84	4,558,780
1/22/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	67,546	$12.55	$847,702.30	4,527,197
1/18/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	39,680	$12.51	$496,396.80	4,434,651
1/16/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	19,599	$12.73	$249,495.27	4,316,046
1/11/2024	Edward P. Feener	Insider	Sell	22,679	$13.03	$295,507.37	39,828
1/10/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	47,700	$12.67	$604,359.00	4,289,800
1/8/2024	Edward P. Feener	Insider	Sell	17,221	$13.01	$224,045.21	62,607
1/8/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	69,184	$12.44	$860,648.96	4,221,284
1/3/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	17,605	$12.20	$214,781.00	4,110,336
12/29/2023	Venrock Healthcare Capital Par	Major Shareholder	Buy	6,013	$12.49	$75,102.37	4,092,731
12/27/2023	Thomas Andrew Crockett	CEO	Sell	30,000	$12.02	$360,600.00	127,532
12/27/2023	Venrock Healthcare Capital Par	Major Shareholder	Buy	41,514	$11.97	$496,922.58	3,615,228
9/11/2023	Albert Cha	Director	Sell	18,000	$10.50	$189,000.00
8/18/2023	Benjamin L Palleiko	CFO	Sell	13,067	$10.73	$140,208.91	95,254
8/18/2023	Paul K Audhya	Insider	Sell	8,020	$10.73	$86,054.60	26,023
8/18/2023	Thomas Andrew Crockett	CEO	Sell	14,876	$10.73	$159,619.48	146,756
5/18/2023	Benjamin L Palleiko	CFO	Sell	4,037	$10.14	$40,935.18	78,126
5/18/2023	Christopher Yea	Insider	Sell	2,604	$10.14	$26,404.56	37,310
5/18/2023	Thomas Andrew Crockett	CEO	Sell	5,627	$10.14	$57,057.78	128,050
2/17/2023	Benjamin L Palleiko	CFO	Sell	4,954	$7.66	$37,947.64	72,799
2/17/2023	Paul K Audhya	Insider	Sell	3,412	$7.66	$26,135.92	9,347
2/17/2023	Thomas Andrew Crockett	CEO	Sell	6,700	$7.66	$51,322.00	120,927
11/18/2022	Benjamin L Palleiko	CFO	Sell	722	$5.44	$3,927.68	68,390
11/18/2022	Christopher Yea	Insider	Sell	1,139	$5.44	$6,196.16	34,232
11/18/2022	Thomas Andrew Crockett	CEO	Sell	1,785	$5.44	$9,710.40	114,878
8/17/2022	Thomas Andrew Crockett	CEO	Sell	1,797	$14.96	$26,883.12	112,178
3/9/2022	Thomas Andrew Crockett	CEO	Sell	10,000	$17.07	$170,700.00

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

SEC Filings (Institutional Ownership Changes) for KalVista Pharmaceuticals (NASDAQ:KALV)

Institutional Buying and Selling by Quarter

KalVista Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/30/2024	Rosalind Advisors Inc.	303,864	$3.52M	2.2%	-10.1%	0.720%
10/29/2024	Emerald Advisers LLC	835,988	$9.68M	0.4%	+29.8%	1.982%
10/29/2024	Emerald Mutual Fund Advisers Trust	650,980	$7.54M	0.4%	+23.0%	1.543%
10/25/2024	China Universal Asset Management Co. Ltd.	8,286	$96K	0.0%	+67.1%	0.020%
10/3/2024	SG Americas Securities LLC	13,189	$0.15M	0.0%	N/A	0.031%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	4,500	$53K	0.0%	-86.6%	0.011%
8/16/2024	Driehaus Capital Management LLC	535,717	$6.31M	0.1%	-1.1%	1.270%
8/15/2024	Susquehanna Fundamental Investments LLC	68,526	$0.81M	0.0%	+323.5%	0.162%
8/15/2024	The Manufacturers Life Insurance Company	15,437	$0.18M	0.0%	+27.3%	0.037%
8/15/2024	Deerfield Management Company L.P. Series C	10,841	$0.13M	0.0%	-29.4%	0.026%
8/14/2024	Great Point Partners LLC	1,338,568	$15.77M	3.0%	N/A	3.173%
8/14/2024	Marshall Wace LLP	48,911	$0.58M	0.0%	-92.2%	0.116%
8/14/2024	Evoke Wealth LLC	15,373	$0.18M	0.2%	N/A	0.036%
8/9/2024	Dimensional Fund Advisors LP	534,979	$6.30M	0.0%	-7.7%	1.268%
8/8/2024	First Turn Management LLC	1,059,540	$12.48M	2.0%	-10.2%	2.511%
8/8/2024	Nicholas Investment Partners LP	184,358	$2.17M	0.2%	+0.9%	0.437%
8/8/2024	American Century Companies Inc.	28,939	$0.34M	0.0%	-11.6%	0.069%
8/7/2024	ClariVest Asset Management LLC	57,096	$0.67M	0.1%	+2.8%	0.135%
8/6/2024	Emerald Advisers LLC	643,897	$7.59M	0.3%	-4.1%	1.507%
8/1/2024	Rhumbline Advisers	53,228	$0.63M	0.0%	+12.5%	0.125%
7/31/2024	nVerses Capital LLC	2,100	$25K	0.0%	N/A	0.005%
7/26/2024	Bank of New York Mellon Corp	135,600	$1.60M	0.0%	+21.0%	0.317%
7/26/2024	AlphaCentric Advisors LLC	2,500	$29K	0.0%	-98.1%	0.006%
7/12/2024	Rosalind Advisors Inc.	337,985	$3.98M	2.9%	+17.4%	0.801%
5/17/2024	Zimmer Partners LP	70,000	$0.83M	0.0%	N/A	0.166%
5/16/2024	California State Teachers Retirement System	3,148	$37K	0.0%	-38.2%	0.007%
5/15/2024	Price T Rowe Associates Inc. MD	22,142	$0.26M	0.0%	+4.5%	0.052%
5/15/2024	PEAK6 Investments LLC	15,000	$0.18M	0.0%	N/A	0.036%
5/14/2024	Capital World Investors	1,464,606	$17.37M	0.0%	N/A	3.471%
5/14/2024	Nan Fung Group Holdings Ltd	219,277	$2.60M	2.4%	-27.9%	0.520%
5/14/2024	EntryPoint Capital LLC	7,784	$92K	0.1%	N/A	0.018%
5/14/2024	StemPoint Capital LP	1,161,060	$13.77M	3.6%	+174.4%	2.752%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	33,500	$0.40M	0.0%	-35.0%	0.079%
5/10/2024	Vanguard Group Inc.	1,685,113	$19.99M	0.0%	-5.4%	3.994%
5/8/2024	Entropy Technologies LP	10,172	$0.12M	0.0%	N/A	0.024%
5/7/2024	Susquehanna Fundamental Investments LLC	16,179	$0.19M	0.0%	N/A	0.038%
5/7/2024	ClariVest Asset Management LLC	55,561	$0.66M	0.1%	N/A	0.132%
5/7/2024	SG Americas Securities LLC	12,082	$0.14M	0.0%	-91.2%	0.029%
5/1/2024	BNP Paribas Financial Markets	18,013	$0.21M	0.0%	+94.5%	0.043%
4/29/2024	Principal Financial Group Inc.	10,234	$0.12M	0.0%	-11.2%	0.024%
4/29/2024	China Universal Asset Management Co. Ltd.	8,024	$95K	0.0%	+101.6%	0.019%
4/25/2024	Rosalind Advisors Inc.	287,985	$3.42M	3.2%	-4.0%	0.683%
2/15/2024	Opaleye Management Inc.	150,000	$1.84M	0.5%	-70.0%	0.434%
2/15/2024	Frazier Life Sciences Management L.P.	3,622,294	$44.37M	2.4%	+11.8%	10.481%
2/13/2024	Tower Research Capital LLC TRC	3,482	$43K	0.0%	+28.3%	0.010%
2/13/2024	Affinity Asset Advisors LLC	125,969	$1.54M	0.3%	-54.7%	0.364%
2/13/2024	Campbell & CO Investment Adviser LLC	41,365	$0.51M	0.0%	N/A	0.120%
2/6/2024	AJOVista LLC	4,920	$60K	0.1%	N/A	0.014%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	10,260	$0.13M	0.0%	N/A	0.030%
1/24/2024	China Universal Asset Management Co. Ltd.	3,981	$49K	0.0%	N/A	0.012%
1/12/2024	SG Americas Securities LLC	137,817	$1.69M	0.0%	+5.1%	0.399%
12/18/2023	Vanguard Group Inc.	1,732,489	$16.68M	0.0%	+9.6%	5.013%
11/15/2023	Adage Capital Partners GP L.L.C.	1,056,691	$10.18M	0.0%	-4.3%	3.072%
11/15/2023	Affinity Asset Advisors LLC	278,292	$2.68M	0.8%	+56.1%	0.809%
11/14/2023	MPM Bioimpact LLC	577,958	$5.57M	1.5%	-24.1%	1.680%
11/14/2023	Nan Fung Group Holdings Ltd	234,573	$2.26M	1.8%	+14.6%	0.682%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	104,668	$1.01M	0.0%	-3.1%	0.304%
11/13/2023	Algert Global LLC	23,250	$0.22M	0.0%	-11.6%	0.068%
11/13/2023	Rathbones Group PLC	19,022	$0.18M	0.0%	N/A	0.055%
11/9/2023	Citigroup Inc.	276,918	$2.67M	0.0%	-7.6%	0.805%
11/7/2023	Quantbot Technologies LP	3,200	$31K	0.0%	N/A	0.009%
11/7/2023	New York State Common Retirement Fund	9,959	$96K	0.0%	+1,860.4%	0.029%
11/7/2023	Jump Financial LLC	10,200	$98K	0.0%	-62.4%	0.030%
11/2/2023	Principal Financial Group Inc.	11,344	$0.11M	0.0%	N/A	0.033%
10/31/2023	Panagora Asset Management Inc.	22,941	$0.22M	0.0%	-12.1%	0.067%
10/26/2023	Strs Ohio	10,800	$0.10M	0.0%	N/A	0.031%
10/24/2023	Bank of New York Mellon Corp	84,309	$0.81M	0.0%	+1.8%	0.245%
10/13/2023	SG Americas Securities LLC	131,147	$1.26M	0.0%	+8.1%	0.381%
9/21/2023	Barclays PLC	4,906	$44K	0.0%	-60.5%	0.014%
8/21/2023	Affinity Asset Advisors LLC	178,292	$1.61M	0.6%	-14.4%	0.520%
8/15/2023	Silverarc Capital Management LLC	720,508	$6.49M	2.0%	-0.4%	2.105%
8/15/2023	Suvretta Capital Management LLC	2,034,506	$18.31M	1.0%	+2.6%	5.944%
8/14/2023	Jefferies Financial Group Inc.	1,030,000	$9.27M	0.1%	-14.2%	3.009%
8/14/2023	Driehaus Capital Management LLC	1,035,935	$9.32M	0.1%	+2.1%	3.026%
8/11/2023	Nan Fung Group Holdings Ltd	204,720	$1.84M	1.2%	+160.1%	0.598%
8/11/2023	Panagora Asset Management Inc.	26,090	$0.24M	0.0%	-43.6%	0.076%
8/11/2023	ExodusPoint Capital Management LP	31,180	$0.28M	0.0%	N/A	0.091%
8/10/2023	Citigroup Inc.	299,808	$2.70M	0.0%	+8.3%	0.876%
8/8/2023	AlphaCentric Advisors LLC	135,000	$1.22M	0.7%	N/A	0.394%
8/7/2023	Acadian Asset Management LLC	8,736	$78K	0.0%	-94.7%	0.026%
8/4/2023	Cibc World Markets Corp	50,000	$0.45M	0.0%	N/A	0.146%
8/3/2023	Los Angeles Capital Management LLC	72,540	$0.65M	0.0%	N/A	0.212%
8/1/2023	Choate Investment Advisors	10,000	$90K	0.0%	N/A	0.029%
7/18/2023	Denali Advisors LLC	29,200	$0.26M	0.1%	+403.4%	0.085%
7/10/2023	SG Americas Securities LLC	121,353	$1.09M	0.0%	N/A	0.355%
5/16/2023	Great Point Partners LLC	1,600,545	$12.58M	2.5%	+51.6%	4.684%
5/16/2023	Boxer Capital LLC	1,650,000	$12.97M	0.6%	N/A	4.829%
5/15/2023	Affinity Asset Advisors LLC	208,292	$1.64M	0.5%	+10.6%	0.610%
5/15/2023	Suvretta Capital Management LLC	1,983,179	$15.59M	0.7%	+84.9%	5.804%
5/12/2023	Prosight Management LP	240,000	$1.89M	0.9%	-61.4%	0.702%
5/11/2023	Acadian Asset Management LLC	164,671	$1.29M	0.0%	-67.6%	0.482%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	99,871	$0.79M	0.0%	+6.9%	0.292%
4/21/2023	Denali Advisors LLC	5,800	$46K	0.0%	-46.3%	0.017%
2/15/2023	Tang Capital Management LLC	3,196,446	$21.61M	3.1%	+77.6%	12.984%
2/15/2023	Jefferies Financial Group Inc.	1,200,000	$8.11M	0.1%	N/A	4.874%
2/14/2023	VR Adviser LLC	2,916,667	$19.72M	3.2%	N/A	11.847%
2/14/2023	Pura Vida Investments LLC	732,702	$4.95M	0.3%	-12.0%	2.976%
2/14/2023	Driehaus Capital Management LLC	1,011,371	$6.84M	0.1%	+91.0%	4.108%
2/13/2023	Vivo Capital LLC	856,008	$5.79M	0.7%	-44.2%	3.477%
2/10/2023	Opaleye Management Inc.	923,200	$6.24M	2.2%	N/A	3.750%

Data available starting January 2016

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $11.25

$10.78

$11.67

50 Day Range

MA: $11.57

$9.46

$13.39

52 Week Range

Now: $11.25

$7.21

$16.88

Volume

622,681 shs

Average Volume

484,001 shs

Market Capitalization

$486.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of KalVista Pharmaceuticals?: KalVista Pharmaceuticals' top insider investors include:
Venrock Healthcare Capital Par (Major Shareholder)
Benjamin L Palleiko (CEO)
Thomas Andrew Crockett (CEO)
Benjamin L Palleiko (CFO)
Christopher Yea (Insider)
Paul K Audhya (Insider)
Edward P Feener (Insider)
Albert Cha (Director)
Learn More about top insider investors at KalVista Pharmaceuticals.
Who are the major institutional investors of KalVista Pharmaceuticals?: KalVista Pharmaceuticals' top institutional shareholders include:
Emerald Advisers LLC — 1.98%
Emerald Mutual Fund Advisers Trust — 1.54%
Rosalind Advisors Inc. — 0.72%
SG Americas Securities LLC — 0.03%
China Universal Asset Management Co. Ltd. — 0.02%
Learn More about top institutional investors of KalVista Pharmaceuticals stock.
Which institutional investors are selling KalVista Pharmaceuticals stock?: In the last quarter, KALV stock was sold by these institutional investors:
Rosalind Advisors Inc.
Within the previous year, company insiders that have sold KalVista Pharmaceuticals company stock include:
Venrock Healthcare Capital Par (Major Shareholder)
Benjamin L Palleiko (CEO)
Thomas Andrew Crockett (CEO)
Benjamin L Palleiko (CFO)
Christopher Yea (Insider)
Paul K Audhya (Insider)
Learn More investors selling KalVista Pharmaceuticals stock.
Which institutional investors are buying KalVista Pharmaceuticals stock?: During the previous quarter, KALV stock was purchased by institutional investors including:
Emerald Advisers LLC
Emerald Mutual Fund Advisers Trust
SG Americas Securities LLC
China Universal Asset Management Co. Ltd.